Media hub
-
Research grant to make gene therapy safer
A team led by Dr Chuck Bailey at the Centenary Institute has been awarded a National Health and Medical Research Council (NHMRC) Ideas Grant to develop safer and more effective gene therapies.News Type: Media releaseDate -
Support for state-of-the-art cancer research projects
The Centenary Institute has received important funding from the RT Hall Trust to bolster two ground-breaking cancer research initiatives. Almost one in two Australians will be diagnosed with cancer by the age of 85. Cancer is a leading cause of death, claiming around 50,000 Australians annually.News Type: Media releaseDate -
Revealing the role of immune cells in liver cancer
New research from the Centenary Institute and the University of Sydney has uncovered important insights into the immune environment within liver cancer, the sixth most common cancer worldwide and the third leading cause of cancer-related deaths.News Type: Media releaseDate -
Grant to advance safer and more precise gene therapy
Centenary Institute researcher Dr Alex Cole has been awarded a $100,000 Ramaciotti Health Investment Grant to support his research into improving the safety and precision of gene therapy treatments.News Type: Media releaseDate -
Research award to advance breast cancer treatments
Dr Mark Schreuder, a researcher at the Centenary Institute’s Centre for Cancer Innovations, has received the Kenyon Foundation Inflammation Award for 2024.News Type: Media releaseDate -
Blood fats predict success of dietary weight loss in pre-diabetes management
New research from the Centenary Institute has identified specific blood fats that can predict how effectively individuals with pre-diabetes will improve their blood sugar levels through diet and weight loss. These findings could pave the way for more personalised approaches to preventing and managing type 2 diabetes.News Type: Media releaseDate -
New genetic tool predicts risk of liver disease in heavy drinkers
An international research group led by the Centenary Institute has developed a new genetic risk prediction tool to identify heavy drinkers most at risk of developing alcohol-associated cirrhosis, a severe form of liver disease.News Type: Media releaseDate -
Prize-winning images showcase the beauty of medical research
The Centenary Institute has announced the winners of its ‘When Art Meets Science’ scientific image prize. The annual prize celebrates the artistic masterpieces captured by Centenary Institute researchers in the course of their ground-breaking medical research.News Type: Media releaseDate -
Key to more effective vaccines revealed
Researchers from the Centenary Institute and the University of Sydney have made a major discovery in vaccine science, gaining new insights into delta inulin as a crucial vaccine component. Their findings offer a promising pathway for advancing the next generation of vaccines.News Type: Media releaseDate -
Advancing melanoma treatment against resistance
Research conducted by the Centenary Institute has revealed a promising new approach to tackling melanoma, an aggressive form of skin cancer notorious for its resistance to conventional treatments.News Type: Media releaseDate -
Research grant to advance ovarian cancer treatment
The Centenary Institute has received vital grant funding from Cancer Australia to lead new research efforts targeting chemotherapy resistance in ovarian cancer patients.News Type: Media releaseDate -
Grant to boost research into age-related blood vessel health
The Centenary Institute’s Professor Jennifer Gamble has been awarded a Senior Researcher Grant under the NSW Cardiovascular Research Capacity Program receiving a total of $750,000 over three years. The grant will fund Professor Gamble’s research into vascular (blood vessel) health to aid healthy ageing and to help prevent disease.News Type: Media releaseDate